How to buy AzurRx BioPharma stock (AZRX)

AzurRx BioPharma is a biotechnology business based in the US. AzurRx BioPharma shares (AZRX) are listed on the NASDAQ and all prices are listed in US Dollars. AzurRx BioPharma employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy AzurRx BioPharma stock

Buy AzurRx BioPharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AzurRx BioPharma stock price (NASDAQ: AZRX)

Use our graph to track the performance of AZRX stocks over time.

AzurRx BioPharma shares at a glance

• Key figures

Information last updated 2022-01-16.

52-week range	$0.00 - $0.00
50-day moving average more info button	$4.94
200-day moving average more info button	$7.50
Wall St. target price	$16.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-15.49

Is it a good time to buy AzurRx BioPharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AzurRx BioPharma financials

Gross profit TTM	$0
Return on assets TTM	-233.79%
Return on equity TTM	-1271.87%
Profit margin	0%
Book value	$0.85
Market Capitalization more info button	$34.4 million

TTM: trailing 12 months

AzurRx BioPharma share dividends

We're not expecting AzurRx BioPharma to pay a dividend over the next 12 months.

Have AzurRx BioPharma's shares ever split?

AzurRx BioPharma's shares were split on a 1:10 basis on 12 September 2021 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AzurRx BioPharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for AzurRx BioPharma shares which in turn could have impacted AzurRx BioPharma's share price.

AzurRx BioPharma share price volatility

Over the last 12 months, AzurRx BioPharma's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AzurRx BioPharma's is 1.5109. This would suggest that AzurRx BioPharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

AzurRx BioPharma overview

AzurRx BioPharma, Inc. , a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology patients; and FW-1022, for COVID-19 gastrointestinal infections. AzurRx BioPharma, Inc. has a license agreement with First Wave Bio, Inc.

Frequently asked questions

null
What percentage of AzurRx BioPharma is owned by insiders or institutions?
Currently 0.767% of AzurRx BioPharma shares are held by insiders and 5.821% by institutions. How many people work for AzurRx BioPharma?
Latest data suggests 12 work at AzurRx BioPharma. When does the fiscal year end for AzurRx BioPharma?
AzurRx BioPharma's fiscal year ends in December. Where is AzurRx BioPharma based?
AzurRx BioPharma's address is: 777 Yamato Road, Boca Raton, FL, United States, 33431 What is AzurRx BioPharma's ISIN number?
AzurRx BioPharma's international securities identification number is: US33749P1012 What is AzurRx BioPharma's CUSIP number?
AzurRx BioPharma's Committee on Uniform Securities Identification Procedures number is: 05502L105